Physician profile
John R Evans
NPI 1245253582
$2,079.73
in general payments reported to CMS, 2019-2025
20 companies · $98.72 in 2025
The $98.72 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $776 · 2020: $51.79 · 2021: $98.75 · 2022: $249 · 2023: $449 · 2024: $356 · 2025: $98.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $904.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $904.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Capsovision, INC. | $600.00 | 2019 | |
| Janssen Biotech, INC. | $265.88 | 2019-2025 | Stelara, Tremfya |
| Regeneron Healthcare Solutions, INC. | $172.49 | 2023-2025 | Dupixent |
| Genzyme Corporation | $137.93 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $136.86 | 2023-2024 | Entyvio |
| Pentax of America, INC. | $132.75 | 2022 | |
| Celgene Corporation | $87.23 | 2023-2024 | Zeposia |
| Shionogi INC | $84.83 | 2019 | |
| Gilead Sciences, INC. | $79.86 | 2021-2023 | |
| Nestle Healthcare Nutrition INC. | $63.10 | 2021-2023 | |
| Exact Sciences Corporation | $55.34 | 2023 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $54.52 | 2019-2020 | |
| Abbvie INC. | $53.45 | 2020-2021 | |
| Boston Scientific Corporation | $42.65 | 2022 | |
| Aimmune Therapeutics, INC. | $21.16 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.10 | 2020 | |
| Ucb, INC. | $20.02 | 2019 | |
| Medtronic Vascular, INC. | $18.66 | 2019 | |
| Braintree Laboratories, INC. | $16.49 | 2025 | Suflave |
| Abbott Laboratories | $15.41 | 2023 | Ensite Precision |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.